Bob's Rx Discount Tidbits

Aducanumab approval--controversial?

Listen Later
A brief overview of the recently approved drug targeting Alzheimer's disease.
...more
View all episodesView all episodes
Download on the App Store
Bob's Rx Discount TidbitsBy Bob Gevelinger